49 PHASE II STUDY ERLOTINIB/RT AND CHT/RT FOLLOWED BY CONSOLIDATION OF CHT FOR PATIENTS WITH STAGE III NON-SMALL CELL LUNG CANCER (NSCLC): ANALYSIS OF PATIENT SPECIMENS FOR BIOMARKERS
In: Radiotherapy and Oncology, Jg. 102 (2012-03-01), S. S16- (2S.)
Online
unknown
Zugriff:
Titel: |
49 PHASE II STUDY ERLOTINIB/RT AND CHT/RT FOLLOWED BY CONSOLIDATION OF CHT FOR PATIENTS WITH STAGE III NON-SMALL CELL LUNG CANCER (NSCLC): ANALYSIS OF PATIENT SPECIMENS FOR BIOMARKERS
|
---|---|
Autor/in / Beteiligte Person: | O'Reilly, Michael S. ; Wei, Xiong ; Lee, J.J. ; Meyn, Raymond E. ; Waun Ki Hong ; Welsh, James W. ; Komaki, R.U. ; Wistuba, I. I. ; Tang, Ximing ; Allen, Pamela K. |
Link: | |
Zeitschrift: | Radiotherapy and Oncology, Jg. 102 (2012-03-01), S. S16- (2S.) |
Veröffentlichung: | Elsevier BV, 2012 |
Medientyp: | unknown |
ISSN: | 0167-8140 (print) |
DOI: | 10.1016/s0167-8140(12)70033-6 |
Schlagwort: |
|
Sonstiges: |
|